Cannabis and CBD for Insomnia: What Does Science Say Today?

Sleep is an active biological process that keeps the brain and body healthy. Yet, according to the CDC, 30.5 percent of American adults reported sleeping fewer than seven hours a night in 2024.

This may explain why many think cannabis is a good sleep aid. (Spoiler alert: It isn’t.) In a survey of medical cannabis users in the United States and Canada, 46 percent reported using cannabis to manage sleep problems.

THC and CBD are cannabinoids used as sleep aids. THC is psychoactive and produces sedation; CBD is not intoxicating. Some products combine both.

During sleep, the brain strengthens memory, regulates emotions, and supports attention and judgment. Sleep also supports metabolic waste clearance, including amyloid-beta, through processes involving the glymphatic system. Healthy sleep promotes immune, metabolic, and cardiovascular health. Chronic sleep deficits are linked with depression, obesity, diabetes, cognitive decline, and dementia.

Why People Turn to Cannabis for Sleep

Imagine being exhausted but unable to fall asleep. Tomorrow you have an important presentation. The harder you try to sleep, the more it eludes you. You remember some THC gummies. You take one and fall asleep. Problem solved, right?

Maybe. But will you sleep longer? Remain asleep? Spend sufficient time in restorative sleep stages? Wake refreshed, with normal attention and judgment? We don’t know. The evidence is hardly reassuring.

Working with Harvard’s Kevin Hill and colleagues, I examined therapeutic cannabis claims in the American Journal of Psychiatry and JAMA. We concluded that cannabinoid medical claims have advanced much faster than scientific evidence or convincing randomized research clinical trials.

Cannabis or CBD is not FDA-approved for chronic insomnia.

Healthy Sleep Architecture

Normal sleep progresses through approximately four to six cycles nightly, involving three non-rapid eye movement (NREM) stages—light sleep (N1), intermediate sleep (N2), and deep sleep (N3)—followed by rapid eye movement (REM) sleep.

Both NREM and REM sleep support healthy brain and body function. Deep NREM sleep contributes to physical restoration and memory consolidation.

Sleep laboratories use polysomnography to record brain activity, eye movements, muscle activity, and other signals. Sleep efficiency measures the percentage of time spent asleep in bed; fragmentation describes repeated sleep interruptions. Sleep is doing important work while we’re doing apparently nothing.

Recent Studies

An October 2026 study in JAMA Network Open examined cannabis exposure and sleep in the long-running CARDIA cohort. The findings were hardly an advertisement for bedtime marijuana.

Greater cumulative cannabis exposure was associated with poorer sleep efficiency, more fragmented sleep, and more time awake after falling asleep. Recent cannabis users also had poorer objectively measured sleep than never-users, despite tending to sleep longer.

But here’s the interesting part: Participants didn’t report correspondingly worse sleep quality.

In other words, people using cannabis may think they’re sleeping just fine. The objective measurements suggest otherwise.

Apparently, feeling that you’ve slept well and actually sleeping well aren't always the same thing. And in the brain, that distinction matters.

Randomized Clinical Trials

In a randomized trial involving 20 adults with insomnia, a single oral dose containing both 10 mg THC and 200 mg CBD reduced total sleep time by approximately 25 minutes and cut REM sleep by 34 minutes. REM onset was delayed by approximately 66 minutes compared with placebo. Of course, one night and 20 participants cannot settle all questions. But these are hardly reassuring results.

Another randomized trial of 150 mg nightly CBD found no significant advantage over placebo on most insomnia outcomes after two weeks. Some secondary outcomes, including self-reported well-being and objectively measured sleep efficiency, showed favorable signals. However, these isolated findings did not help support clinically meaningful treatment of insomnia.

A systematic review of 39 randomized trials involving 5,100 patients found small improvements in sleep-related outcomes with medical cannabinoids, primarily among patients with chronic pain.

Last but not least, an influential Cochrane review was published in October 2026 that specifically examined medical cannabis for insomnia. Its conclusion was a wake-up call, not an endorsement. Compared with placebo, cannabis may have little or no clinically meaningful effect on sleep quality, total sleep time, or daytime functioning.

Cannabis’s insomnia evidence was highly uncertain, and Cochrane called for larger, longer randomized trials. This is not evidence that cannabis can never work. It shows that, currently, proof of benefit remains elusive.

Addiction and Withdrawal

So, a person begins using THC to sleep. Initially, it seems helpful. But often subsequent nightly use follows.

With repeated use, people develop tolerance and dependence. When they stop, withdrawal can produce insomnia, vivid dreams, irritability, and anxiety. Resuming cannabis relieves these symptoms.

The conclusion practically writes itself: “I knew I needed it.”

But relieving withdrawal insomnia doesn’t prove the first use for insomnia was successful.

Sleep disturbance is a common symptom of cannabis withdrawal. It can persist for weeks after cessation and may contribute to relapse.

Of course, not everyone using THC for sleep develops cannabis use disorder (CUD). But it’s a risk.

What Actually Works for Insomnia?

Physicians should first determine why a patient cannot sleep. Pain, depression, anxiety, alcohol, medications, sleep apnea, and circadian disturbances, once diagnosed, require specific treatment.

Cognitive behavioral therapy for insomnia (CBT-I) is the recommended first-line treatment for chronic insomnia. It has substantial randomized-trial support and produces long-lasting benefits without medication use or drug dependence.

Cannabinoids should be compared with CBT-I and established FDA-approved insomnia treatments. They have not demonstrated sufficient long-term safety and efficacy to justify their routine use for chronic insomnia. Not so far.

Bottom Line

Cannabis researchers need longer-duration randomized trials comparing standardized THC and CBD preparations with placebo and FDA-approved treatments. Studies should measure sleep architecture and next-day cognition, as well as tolerance, withdrawal and addiction risks, and sustained benefits.

Sleeping well is too important to leave to an unapproved, poorly tested, and possibly harmful treatment. Protect your brain and overall health. And if you have insomnia, consult your physician.

References